P

Inventor

PATTERSON KRISTIN

US32 patents
⚠️ This page may combine multiple inventors who share the name “PATTERSON KRISTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SPRINGWORKS THERAPEUTICS INC

28 patents
US11872211B2Jan 16, 2024

Treatments with nirogacestat

SPRINGWORKS THERAPEUTICS INC12 citations93
US11427534B1Aug 30, 2022

Solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide and uses thereof

SPRINGWORKS THERAPEUTICS INC19 citations91
US11084780B1Aug 10, 2021

Crystalline solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof

SPRINGWORKS THERAPEUTICS INC24 citations91
US11612588B1Mar 28, 2023

Chlorinated tetralin compounds and pharmaceutical compositions

SPRINGWORKS THERAPEUTICS INC5 citations85
US11571402B2Feb 7, 2023

Dispersible formulations of N-((R)-2,3-dihydroxypropoly)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof

SPRINGWORKS THERAPEUTICS INC7 citations85
US11504354B1Nov 22, 2022

Chlorinated tetralin compounds and pharmaceutical compositions

SPRINGWORKS THERAPEUTICS INC8 citations85
US11957662B2Apr 16, 2024

Treatments with nirogacestat

SPRINGWORKS THERAPEUTICS INC8 citations84
US11951096B2Apr 9, 2024

Treatments with nirogacestat

SPRINGWORKS THERAPEUTICS INC8 citations84
US11938116B2Mar 26, 2024

Treatments with nirogacestat

SPRINGWORKS THERAPEUTICS INC8 citations84
US11925620B1Mar 12, 2024

Treatments with nirogacestat

SPRINGWORKS THERAPEUTICS INC8 citations84
US11925619B2Mar 12, 2024

Treatments with nirogacestat

SPRINGWORKS THERAPEUTICS INC8 citations84
US12029711B1Jul 9, 2024

Dosage forms of mirdametinib

SPRINGWORKS THERAPEUTICS INC6 citations83
US12234210B2Feb 25, 2025

Synthesis of nirogacestat

SPRINGWORKS THERAPEUTICS INC2 citations74
US12090128B2Sep 17, 2024

Dispersible formulations of n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benazmide and uses thereof

SPRINGWORKS THERAPEUTICS INC2 citations73
US12138246B2Nov 12, 2024

Treatments with nirogacestat

SPRINGWORKS THERAPEUTICS INC2 citations72
US12110277B2Oct 8, 2024

Synthesis of nirogacestat

SPRINGWORKS THERAPEUTICS INC2 citations72
US12036207B2Jul 16, 2024

Treatments with nirogacestat

SPRINGWORKS THERAPEUTICS INC2 citations72
US12011434B2Jun 18, 2024

Treatments with nirogacestat

SPRINGWORKS THERAPEUTICS INC2 citations72
US12011435B2Jun 18, 2024

Treatments with nirogacestat

SPRINGWORKS THERAPEUTICS INC2 citations72
US11844780B2Dec 19, 2023

Chlorinated tetralin compounds and pharmaceutical compositions

SPRINGWORKS THERAPEUTICS INC2 citations72
US11807611B2Nov 7, 2023

Chlorinated tetralin compounds and pharmaceutical compositions

SPRINGWORKS THERAPEUTICS INC3 citations72
US11884610B2Jan 30, 2024

Crystalline solids of mek inhibitor n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof

SPRINGWORKS THERAPEUTICS INC2 citations70
US12357597B2Jul 15, 2025

Dispersible formulations of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benazmide and uses thereof

SPRINGWORKS THERAPEUTICS INC0 citations62
US12247012B2Mar 11, 2025

Synthesis of nirogacestat

SPRINGWORKS THERAPEUTICS INC0 citations62
US12186305B2Jan 7, 2025

Treatments with nirogacestat

SPRINGWORKS THERAPEUTICS INC0 citations61
US12383517B2Aug 12, 2025

Dosage forms of mirdametinib

SPRINGWORKS THERAPEUTICS INC0 citations60
US12275688B2Apr 15, 2025

Crystalline solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof

SPRINGWORKS THERAPEUTICS INC0 citations60
US11780800B1Oct 10, 2023

Fluorinated phenylamino compounds and pharmaceutical compositions

SPRINGWORKS THERAPEUTICS INC0 citations58

AT & T IP I LP

4 patents